急性肺损伤市场基于(关键地区、市场参与者、规模和份额)- 到 2031 年的预测

  • Report Code : TIPRE00015798
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 141
Buy Now

急性肺损伤市场预计将从 2021 年的 5.3961 亿美元增至 2028 年的 7.4198 亿美元;预计 2021 年至 2028 年复合年增长率为 4.7%。

急性肺损伤 (ALI) 是危及生命的危重疾病。在急性肺损伤疾病中,肺部发生急性炎症,导致肺内皮和上皮屏障破坏。肺泡毛细血管膜由微血管内皮、间质和肺泡上皮组成。急性肺损伤市场是根据危重患者出现非心源性肺水肿和呼吸衰竭进行临床诊断的。其发病率是正常的;它很可能存在于重症监护室之外,因此是与所有临床医生相关的病症。

该报告提供了对急性肺损伤的见解和深入分析市场,强调各种参数,例如市场趋势、技术进步、市场动态以及全球领先市场参与者的竞争格局分析。它还包括 COVID-19 大流行对所有地区市场的影响。 COVID-19 大流行扰乱了世界各国的社会经济状况。根据世界卫生组织最新统计数据,目前,美国是世界上受新冠肺炎疫情影响最严重的国家,确诊病例和死亡人数最多。大量新冠病例对该国家和地区的经济产生了负面影响。该地区的整体商业活动有所下降,各行业的增长也有所下降。

但是,急性肺损伤市场参与者正在启动临床试验,开发药物来治疗急性肺损伤。治疗急性肺损伤。例如,生物制药公司 Chimerix 于 2020 年 6 月启动了一项 II/III 期临床试验,以评估多西帕司他钠 (DSTAT) 在治疗因 COVID-19 导致的急性肺损伤 (ALI) 患者中的安全性和有效性。此外,Altasciences 很高兴通过开展 I 期试验来支持 ReAlta Life Sciences,以评估 RLS-0071 治疗因 COVID-19、呼吸道合胞病毒 (RSV) 和流感等病毒感染引起的急性肺损伤 (ALI) 的效果。 COVID-19 相关问题推动了该地区急性肺损伤市场的增长。

根据地区,市场分为北美、欧洲、亚太地区、中东和非洲。非洲、南美洲和中美洲。

急性肺损伤市场利润丰厚的地区


市场洞察

呼吸系统疾病患病率的增加推动了急性肺损伤市场

呼吸系统疾病的高患病率与肺损伤规模的减小有关老年人的上呼吸道管腔。肺部疾病是世界上最常见的疾病之一。根据美国疾病控制与预防中心 (CDC) 的数据,慢性阻塞性肺病 (COPD) 和急性肺损伤 (ALI) 等肺部疾病是美国第三大死亡原因。世界各地的人们都患有各种呼吸系统疾病。吸烟、感染和遗传因素是导致呼吸系统疾病的常见因素。慢性阻塞性肺病、哮喘、慢性支气管炎、囊性纤维化和肺癌等疾病是重大的公共卫生负担。

患有这些呼吸系统疾病的患者通常会出现呼吸困难。与急性肺损伤或急性呼吸窘迫综合征 (ARDS) 相关的呼吸衰竭是术后死亡的最关键因素之一。

此外,CDC、美国食品和药物管理局 (FDA)、州和地方卫生部门以及其他临床和公共卫生部门继续监测与吸烟电子烟或电子烟产品使用相关的肺损伤 (EVALI)。据 CDC 统计,截至 2020 年 2 月,全美 50 个州、哥伦比亚特区和两个美国领土(波多黎各和美属维尔京群岛)共记录了 2,807 例住院 EVALI 病例或死亡。因此,上述所有因素上述预计将导致预测期内急性肺损伤市场的增长。

基于治疗的见解

基于治疗,急性肺损伤市场分为机械通气、液体管理、药物治疗和辅助治疗。 2021年,机械通气细分市场在全球急性肺损伤市场中占据最大市场份额。该领域的增长归因于急性肺损伤(ALI)中机械通气的目的是维持氧气,同时避免与通气相关的毒性和并发症。

急性肺损伤市场,按治疗分类 - 2020 年和 2028 年


基于最终用户的见解

基于最终用户,敏锐的洞察力肺损伤市场分为医院、门诊手术中心等。 2021 年,医院细分市场占据最大市场份额,预计该细分市场在预测期内的复合年增长率最高,为 4.9%。

战略见解

急性肺损伤市场参与者采用产品推出和扩张等有机战略,以扩大其在全球的足迹和产品组合,并满足不断增长的需求。

 

通过治疗

  • 机械通气
  • 液体管理
  • 药物治疗
  • 辅助程序

最终用户

  • 医院
  • 门诊手术中心
  • 其他

按地理位置

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 法国
    • 德国
    • 意大利
    • 英国
    • 西班牙
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳大利亚
    • 亚太地区其他地区
  • 中东和美国非洲 (MEA)
    • 南非
    • 沙特阿拉伯
    • 阿联酋
    • 中东和非洲其他地区
  • 南美洲和中美洲 (SCAM)
    • 巴西
    • 阿根廷
    • 其他 SCAM
ul>


公司简介

  • 葛兰素史克公司。
  • Stemedica Cell Technologies, Inc.
  • Histocell
  • APEPTICO Forschung und Entwicklung GmbH
  • Windtree Therapeutics, Inc.
  • ReAlta Life Sciences, Inc.
  • Apeiron Biologics AG
  • Qx Therapeutics, Inc.
  • Angion
  • Asklepion Pharmaceuticals, LLC ;                          &n公共服务提供商;                   
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which is the potential market for the acute lung injury in terms of region?

Asia Pacific is expected to be the fastest growing region and potential market for acute lung injury. Asia Pacific is expected to expand at a high growth rate. The growth of the acute lung injury market in this region is primarily due to high prevalence of this disease, and the rise in healthcare awareness related to the disease diagnosis. Additionally, developing healthcare infrastructure and increasing investments to boost the manufacturing capacities are projected to drive the Asia Pacific acute lung injury market during the forecast period.

What are the drivers and restraints for the acute lung injury market?

The growth of the market is attributed to increasing prevalence of respiratory diseases, and rising geriatric population drive the market growth. However, high cost of therapies hampers the market growth.

Who are the key players in the acute lung injury market?

The acute lung injury market majorly consists of players like GlaxoSmithKline plc., Stemedica Cell Technologies, Inc, Histocell, APEPTICO Forschung und Entwicklung GmbH, Windtree Therapeutics, Inc., ReAlta Life Sciences, Inc., Apeiron Biologics AG, Qx Therapeutics, Inc., Angion, and Asklepion Pharmaceuticals, LLC. among others. Histocell and APEPTICO Forschung und Entwicklung GmbH are the top most two companies in the market.

The List of Companies - Acute Lung Injury Market

  1. GlaxoSmithKline plc.
  2. Stemedica Cell Technologies, Inc
  3. Histocell
  4. APEPTICO Forschung und Entwicklung GmbH
  5. Windtree Therapeutics, Inc.
  6. ReAlta Life Sciences, Inc.
  7. Apeiron Biologics AG
  8. Qx Therapeutics, Inc.
  9. Angion
  10. Asklepion Pharmaceuticals, LLC

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports